-
Product Insights
Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lipodystrophy (Lipoatrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lipodystrophy (Lipoatrophy) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lipodystrophy (Lipoatrophy), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Lysosomal Storage Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Lysosomal Storage Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lysosomal Storage Disorder, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Metabolic Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Metabolic Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Growth Hormone Deficiency pipeline landscape. The report provides comprehensive information on the therapeutics under development for Growth Hormone Deficiency, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
-
Product Insights
Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hyperlipidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hyperlipidemia, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Cushings Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Cushing's Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Cushing's Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cushing's Syndrome, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Sector Analysis
Amyloidosis - Epidemiology Forecast to 2029
Amyloidosis is a rare disease characterized by extracellular and/or intracellular deposition of insoluble abnormal amyloid fibrils that alters the normal functions of the tissues in the organs (Holmes et al., 2019; Mayo Clinic, 2020). Amyloid is not normally found in the body, but it can be formed from several different types of protein and interferes with the organs’ normal function. Organs that may be affected by amyloidosis include the heart, kidneys, liver, spleen, nervous system, and digestive tract (Mayo Clinic,...
-
Product Insights
Amyloidosis Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2020" provides an overview of Amyloidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Diabetic Retinopathy Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2020" provides an overview of Diabetic Retinopathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Nephropathy Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2020" provides an overview of Diabetic Nephropathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.